- Published on
Ophthalmology – Esotropia (Infantile)
Infantile esotropia is a large-angle inward deviation of the eyes that develops within the first 6 months of life in an otherwise healthy infant. It is characterized by a constant deviation typically greater than 35 prism diopters, full ocular motility, and minimal or no significant refractive error. Unlike other forms of esotropia, amblyopia is less common at initial presentation, although it may develop later.
This condition accounts for approximately 8% of all childhood esotropia, with overall esotropia affecting about 2% of children under 6 years. A family history of strabismus is a recognized risk factor.
The underlying pathophysiology is thought to involve abnormal binocular visual development early in life. Studies suggest that disruption of normal sensory input during a critical developmental period leads to persistent ocular misalignment. Early restoration of alignment improves binocular outcomes and reduces later complications.
Infantile esotropia is frequently associated with other ocular motor abnormalities that may develop over time. These include inferior oblique overaction, latent nystagmus, dissociated vertical deviation (DVD), and cross-fixation behavior. Cross-fixation, where the child uses the left eye to look right and vice versa, may simulate an abduction deficit but actually reflects preserved motility.
Parents usually notice eye crossing at birth or within the first few months of life. On examination, there is a large, constant, comitant esotropia with normal ocular structures. Refractive error is typically mild (around +2 diopters, normal for age). Fixation may alternate between eyes; if not, amblyopia should be suspected. Apparent limitation of abduction can often be overcome using cover testing or the Doll’s head maneuver, confirming full extraocular movement.
Neuroimaging is not routinely required, but should be considered if there are abnormal eye movements, atypical features, or significant nystagmus.
The differential diagnosis includes pseudoesotropia, Duane syndrome (Type I), Moebius syndrome, congenital sixth nerve palsy, orbital tumors, and nystagmus blockage syndrome.
Management is primarily surgical, with the goal of achieving early ocular alignment to support binocular vision development. The most common procedure is bilateral medial rectus recession, although larger deviations may require additional muscle surgery. Alignment should ideally be achieved before 24 months of age, and earlier intervention may provide better sensory outcomes.
Before surgery, it is important to treat any amblyopia and correct significant refractive errors to rule out an accommodative component. Although rare, spontaneous resolution can occur, but this is not typically relied upon.
Long-term follow-up is essential. Up to 50% of patients may require additional strabismus surgery by age 10 due to recurrence or development of associated conditions such as inferior oblique overaction or DVD. Patients must also be monitored for amblyopia, refractive errors, and secondary accommodative esotropia.
Parents should be counseled regarding the chronic nature of the condition and the need for ongoing monitoring and possible multiple interventions. If amblyopia persists, protective polycarbonate glasses are recommended.
The prognosis for visual acuity is generally good, with most children achieving normal vision in both eyes. However, stereopsis (depth perception) is often poor unless early alignment is achieved.
Complications include recurrent or consecutive strabismus and amblyopia, both of which may require further treatment.
Infantile esotropia is a large-angle inward deviation of the eyes that develops within the first 6 months of life in an otherwise healthy infant. It is characterized by a constant deviation typically greater than 35 prism diopters, full ocular motility, and minimal or no significant refractive error. Unlike other forms of esotropia, amblyopia is less common at initial presentation, although it may develop later.
This condition accounts for approximately 8% of all childhood esotropia, with overall esotropia affecting about 2% of children under 6 years. A family history of strabismus is a recognized risk factor.
The underlying pathophysiology is thought to involve abnormal binocular visual development early in life. Studies suggest that disruption of normal sensory input during a critical developmental period leads to persistent ocular misalignment. Early restoration of alignment improves binocular outcomes and reduces later complications.
Infantile esotropia is frequently associated with other ocular motor abnormalities that may develop over time. These include inferior oblique overaction, latent nystagmus, dissociated vertical deviation (DVD), and cross-fixation behavior. Cross-fixation, where the child uses the left eye to look right and vice versa, may simulate an abduction deficit but actually reflects preserved motility.
Parents usually notice eye crossing at birth or within the first few months of life. On examination, there is a large, constant, comitant esotropia with normal ocular structures. Refractive error is typically mild (around +2 diopters, normal for age). Fixation may alternate between eyes; if not, amblyopia should be suspected. Apparent limitation of abduction can often be overcome using cover testing or the Doll’s head maneuver, confirming full extraocular movement.
Neuroimaging is not routinely required, but should be considered if there are abnormal eye movements, atypical features, or significant nystagmus.
The differential diagnosis includes pseudoesotropia, Duane syndrome (Type I), Moebius syndrome, congenital sixth nerve palsy, orbital tumors, and nystagmus blockage syndrome.
Management is primarily surgical, with the goal of achieving early ocular alignment to support binocular vision development. The most common procedure is bilateral medial rectus recession, although larger deviations may require additional muscle surgery. Alignment should ideally be achieved before 24 months of age, and earlier intervention may provide better sensory outcomes.
Before surgery, it is important to treat any amblyopia and correct significant refractive errors to rule out an accommodative component. Although rare, spontaneous resolution can occur, but this is not typically relied upon.
Long-term follow-up is essential. Up to 50% of patients may require additional strabismus surgery by age 10 due to recurrence or development of associated conditions such as inferior oblique overaction or DVD. Patients must also be monitored for amblyopia, refractive errors, and secondary accommodative esotropia.
Parents should be counseled regarding the chronic nature of the condition and the need for ongoing monitoring and possible multiple interventions. If amblyopia persists, protective polycarbonate glasses are recommended.
The prognosis for visual acuity is generally good, with most children achieving normal vision in both eyes. However, stereopsis (depth perception) is often poor unless early alignment is achieved.
Complications include recurrent or consecutive strabismus and amblyopia, both of which may require further treatment.
- Published on
Toxicology – Drugs Causing Hyperventilation
Aspirin (Salicylates)
Salicylates directly stimulate the respiratory center in the central nervous system, leading to increased respiratory rate and the development of respiratory alkalosis.
Amphetamines (Speed)
Amphetamines and other sympathomimetic agents elevate catecholamine levels, resulting in increased heart rate, blood pressure, and respiratory rate, often causing hyperventilation.
Paraquat
Paraquat, a toxic herbicide, causes direct lung injury leading to impaired oxygen exchange. This results in hypoxia and compensatory hyperventilation.
Phencyclidine (PCP)
PCP is a dissociative anesthetic that produces minimal cardiopulmonary depression. Patients may fluctuate between sedation and agitation, with hyperventilation commonly occurring during agitated states.
Noncardiogenic Pulmonary Edema (NCPE)
Various toxins can lead to noncardiogenic pulmonary edema, impairing gas exchange and triggering hyperventilation. Inhaled causes include ammonia, chlorine gas, solvents, hydrocarbons, hydrogen sulfide, and phosgene. Oral or parenteral agents include heroin, methadone, naloxone, salicylates, NSAIDs, and certain chemotherapeutic drugs.
Toxin-Induced Metabolic Acidosis
Certain toxins produce metabolic acidosis, which stimulates compensatory hyperventilation (hyperpnea) as the body attempts to reduce carbon dioxide levels and correct acidemia.
Aspirin (Salicylates)
Salicylates directly stimulate the respiratory center in the central nervous system, leading to increased respiratory rate and the development of respiratory alkalosis.
Amphetamines (Speed)
Amphetamines and other sympathomimetic agents elevate catecholamine levels, resulting in increased heart rate, blood pressure, and respiratory rate, often causing hyperventilation.
Paraquat
Paraquat, a toxic herbicide, causes direct lung injury leading to impaired oxygen exchange. This results in hypoxia and compensatory hyperventilation.
Phencyclidine (PCP)
PCP is a dissociative anesthetic that produces minimal cardiopulmonary depression. Patients may fluctuate between sedation and agitation, with hyperventilation commonly occurring during agitated states.
Noncardiogenic Pulmonary Edema (NCPE)
Various toxins can lead to noncardiogenic pulmonary edema, impairing gas exchange and triggering hyperventilation. Inhaled causes include ammonia, chlorine gas, solvents, hydrocarbons, hydrogen sulfide, and phosgene. Oral or parenteral agents include heroin, methadone, naloxone, salicylates, NSAIDs, and certain chemotherapeutic drugs.
Toxin-Induced Metabolic Acidosis
Certain toxins produce metabolic acidosis, which stimulates compensatory hyperventilation (hyperpnea) as the body attempts to reduce carbon dioxide levels and correct acidemia.
- Published on
Ophthalmology – Crohn’s Disease & Ulcerative Colitis (IBD)
Inflammatory bowel disease (IBD), which includes Crohn’s disease (CD) and ulcerative colitis (UC), is a chronic inflammatory condition of the gastrointestinal tract with important extra-intestinal manifestations, including the eye. Ocular involvement can affect nearly all layers of the eye, ranging from mild surface inflammation to severe vision-threatening disease. The most common ophthalmic manifestations include episcleritis, anterior uveitis, scleritis, keratitis, and retinal vasculitis. Although ocular disease is not usually the presenting feature of IBD, it occurs in 3.5–11.8% of patients, with Crohn’s disease generally having more ocular involvement than ulcerative colitis.
The underlying mechanism involves a systemic inflammatory response driven by immune dysregulation in genetically predisposed individuals. This results in infiltration of inflammatory mediators into ocular tissues, leading to edema, tissue damage, and dysfunction. Genetic associations such as HLA-B27 significantly increase the risk of ocular inflammation, particularly acute anterior uveitis. Other associated HLA types include HLA-B58 and HLA-DRB1 variants.
Clinically, symptoms depend on the structure involved. Episcleritis presents with mild redness and irritation without vision loss and often correlates with intestinal disease activity. Anterior uveitis causes pain, photophobia, and blurred vision and may occur independently of bowel disease activity. Scleritis is more severe, presenting with deep, boring pain and tenderness and can threaten vision. Keratitis produces sharp pain and photophobia, while posterior uveitis or retinal vasculitis may lead to blurred vision and retinal complications such as macular edema.
On examination, slit-lamp findings vary by condition. Episcleritis shows superficial redness that blanches with phenylephrine, whereas scleritis shows deeper inflammation that does not blanch and is often tender. Anterior uveitis demonstrates ciliary flush with cells and flare in the anterior chamber. Posterior involvement may reveal vitreous inflammation, vascular sheathing, or macular edema, often requiring imaging such as fluorescein angiography. A B-scan ultrasound may show a characteristic T-sign in posterior scleritis.
Management depends on severity. Episcleritis is usually mild and treated with artificial tears or topical steroids if needed. Anterior uveitis requires intensive topical steroids and cycloplegics. Scleritis often needs systemic therapy such as oral NSAIDs or corticosteroids. More severe or refractory cases—including keratitis and posterior uveitis—may require systemic immunosuppressive therapy such as methotrexate, azathioprine, or anti-TNF agents. Close collaboration with gastroenterology is important, as control of systemic IBD activity helps reduce ocular inflammation.
Follow-up is essential until inflammation resolves. Patients on long-term corticosteroids must be monitored for glaucoma and cataracts, while ongoing inflammation can lead to complications such as macular edema or, rarely, phthisis bulbi. Overall prognosis is generally good, as most patients respond well to treatment, especially when diagnosed early and managed appropriately.
Inflammatory bowel disease (IBD), which includes Crohn’s disease (CD) and ulcerative colitis (UC), is a chronic inflammatory condition of the gastrointestinal tract with important extra-intestinal manifestations, including the eye. Ocular involvement can affect nearly all layers of the eye, ranging from mild surface inflammation to severe vision-threatening disease. The most common ophthalmic manifestations include episcleritis, anterior uveitis, scleritis, keratitis, and retinal vasculitis. Although ocular disease is not usually the presenting feature of IBD, it occurs in 3.5–11.8% of patients, with Crohn’s disease generally having more ocular involvement than ulcerative colitis.
The underlying mechanism involves a systemic inflammatory response driven by immune dysregulation in genetically predisposed individuals. This results in infiltration of inflammatory mediators into ocular tissues, leading to edema, tissue damage, and dysfunction. Genetic associations such as HLA-B27 significantly increase the risk of ocular inflammation, particularly acute anterior uveitis. Other associated HLA types include HLA-B58 and HLA-DRB1 variants.
Clinically, symptoms depend on the structure involved. Episcleritis presents with mild redness and irritation without vision loss and often correlates with intestinal disease activity. Anterior uveitis causes pain, photophobia, and blurred vision and may occur independently of bowel disease activity. Scleritis is more severe, presenting with deep, boring pain and tenderness and can threaten vision. Keratitis produces sharp pain and photophobia, while posterior uveitis or retinal vasculitis may lead to blurred vision and retinal complications such as macular edema.
On examination, slit-lamp findings vary by condition. Episcleritis shows superficial redness that blanches with phenylephrine, whereas scleritis shows deeper inflammation that does not blanch and is often tender. Anterior uveitis demonstrates ciliary flush with cells and flare in the anterior chamber. Posterior involvement may reveal vitreous inflammation, vascular sheathing, or macular edema, often requiring imaging such as fluorescein angiography. A B-scan ultrasound may show a characteristic T-sign in posterior scleritis.
Management depends on severity. Episcleritis is usually mild and treated with artificial tears or topical steroids if needed. Anterior uveitis requires intensive topical steroids and cycloplegics. Scleritis often needs systemic therapy such as oral NSAIDs or corticosteroids. More severe or refractory cases—including keratitis and posterior uveitis—may require systemic immunosuppressive therapy such as methotrexate, azathioprine, or anti-TNF agents. Close collaboration with gastroenterology is important, as control of systemic IBD activity helps reduce ocular inflammation.
Follow-up is essential until inflammation resolves. Patients on long-term corticosteroids must be monitored for glaucoma and cataracts, while ongoing inflammation can lead to complications such as macular edema or, rarely, phthisis bulbi. Overall prognosis is generally good, as most patients respond well to treatment, especially when diagnosed early and managed appropriately.
- Published on
Ophthalmology – Conjunctival Lymphoma
Conjunctival lymphoma is part of a spectrum of lymphoid tumors ranging from benign reactive hyperplasia to malignant lymphoma. It represents a form of extranodal lymphoma, meaning it arises outside lymph nodes, and accounts for a small proportion of all lymphomas. Within the eye, lymphoma can involve multiple structures including the conjunctiva, orbit, eyelid, uvea, retina, and vitreous. Importantly, conjunctival lymphoma may be the first manifestation of a systemic, potentially life-threatening lymphoma, making early recognition critical.
Clinically, it most often affects middle-aged to older adults and is rare in children. Patients may present with a painless, pink (“salmon-patch”) conjunctival mass, which is a key hallmark. Some individuals notice irritation, tearing, or a visible lesion, while others are completely asymptomatic. The tumor commonly arises in the fornix or midbulbar conjunctiva and can occasionally be multifocal or bilateral. Although many cases are initially localized, a significant proportion of patients may later develop systemic lymphoma, sometimes even decades after the ocular diagnosis.
The underlying pathophysiology is not fully understood, but many cases are classified as MALT (mucosa-associated lymphoid tissue) lymphoma. Chronic immune stimulation is believed to play a role, possibly related to infections such as Helicobacter pylori or Chlamydia psittaci, or autoimmune diseases like Sjögren’s syndrome or Hashimoto thyroiditis. Genetic abnormalities, including chromosomal translocations, have also been identified in some cases.
Diagnosis begins with clinical suspicion based on appearance, but definitive diagnosis requires biopsy. Histopathology helps distinguish between reactive hyperplasia, atypical lymphoid proliferation, and true malignant lymphoma. Additional evaluation includes CBC to rule out leukemia, as well as imaging—preferably orbital MRI—to assess for local extension. Because of the risk of systemic involvement, patients require long-term systemic surveillance, often with periodic imaging and medical evaluation.
Management depends on the extent and behavior of the tumor. Small, localized lesions may be treated with complete surgical excision combined with cryotherapy. If the lesion is diffuse or involves critical structures, an incisional biopsy followed by therapy is preferred. Treatment options include radiotherapy, which is highly effective due to the radiosensitive nature of lymphoma, as well as chemotherapy and immunotherapy (e.g., rituximab). Some clinicians also use antibiotics targeting suspected infectious triggers.
Long-term follow-up is essential, as recurrence or systemic progression can occur even many years later. Patients are typically monitored at least twice yearly with ocular exams and periodic systemic evaluation. Prognosis is generally favorable for localized disease, but the risk of systemic lymphoma varies—higher in bilateral cases than unilateral ones. Potential complications include ocular motility problems, ptosis, diplopia, or vision loss, particularly after treatment.
Conjunctival lymphoma is part of a spectrum of lymphoid tumors ranging from benign reactive hyperplasia to malignant lymphoma. It represents a form of extranodal lymphoma, meaning it arises outside lymph nodes, and accounts for a small proportion of all lymphomas. Within the eye, lymphoma can involve multiple structures including the conjunctiva, orbit, eyelid, uvea, retina, and vitreous. Importantly, conjunctival lymphoma may be the first manifestation of a systemic, potentially life-threatening lymphoma, making early recognition critical.
Clinically, it most often affects middle-aged to older adults and is rare in children. Patients may present with a painless, pink (“salmon-patch”) conjunctival mass, which is a key hallmark. Some individuals notice irritation, tearing, or a visible lesion, while others are completely asymptomatic. The tumor commonly arises in the fornix or midbulbar conjunctiva and can occasionally be multifocal or bilateral. Although many cases are initially localized, a significant proportion of patients may later develop systemic lymphoma, sometimes even decades after the ocular diagnosis.
The underlying pathophysiology is not fully understood, but many cases are classified as MALT (mucosa-associated lymphoid tissue) lymphoma. Chronic immune stimulation is believed to play a role, possibly related to infections such as Helicobacter pylori or Chlamydia psittaci, or autoimmune diseases like Sjögren’s syndrome or Hashimoto thyroiditis. Genetic abnormalities, including chromosomal translocations, have also been identified in some cases.
Diagnosis begins with clinical suspicion based on appearance, but definitive diagnosis requires biopsy. Histopathology helps distinguish between reactive hyperplasia, atypical lymphoid proliferation, and true malignant lymphoma. Additional evaluation includes CBC to rule out leukemia, as well as imaging—preferably orbital MRI—to assess for local extension. Because of the risk of systemic involvement, patients require long-term systemic surveillance, often with periodic imaging and medical evaluation.
Management depends on the extent and behavior of the tumor. Small, localized lesions may be treated with complete surgical excision combined with cryotherapy. If the lesion is diffuse or involves critical structures, an incisional biopsy followed by therapy is preferred. Treatment options include radiotherapy, which is highly effective due to the radiosensitive nature of lymphoma, as well as chemotherapy and immunotherapy (e.g., rituximab). Some clinicians also use antibiotics targeting suspected infectious triggers.
Long-term follow-up is essential, as recurrence or systemic progression can occur even many years later. Patients are typically monitored at least twice yearly with ocular exams and periodic systemic evaluation. Prognosis is generally favorable for localized disease, but the risk of systemic lymphoma varies—higher in bilateral cases than unilateral ones. Potential complications include ocular motility problems, ptosis, diplopia, or vision loss, particularly after treatment.
- Published on
Ophthalmology – Congenital Hypopigmented Retinal Lesions
Congenital hypopigmented retinal lesions are a diverse group of conditions characterized by reduced or absent pigmentation of the retinal pigment epithelium (RPE) or choroid present at birth. These lesions are not a single disease entity but rather include a wide spectrum of pathologies such as tumors, congenital infections, retinal dystrophies, and developmental abnormalities. Clinically, they may appear as white or pale areas in the fundus and can vary in size, location, and associated findings.
A critical point in evaluation is that any white retinal lesion in infancy must prompt urgent consideration of Retinoblastoma, a life-threatening malignancy. Other important causes include infectious etiologies such as Toxoplasmosis, Cytomegalovirus infection, and Varicella, which typically produce chorioretinal scars. Developmental anomalies like Coloboma and inherited retinal dystrophies such as Leber congenital amaurosis are also included in the differential diagnosis.
The underlying pathophysiology depends on the cause. In some cases, there is a primary defect in melanin production within the RPE, while in others, such as infections, there is destruction of the RPE. Developmental conditions like coloboma result from failure of closure of the embryonic fissure, leading to absence of normal retinal and choroidal structures. Neoplastic processes, such as retinoblastoma or astrocytic hamartoma, involve abnormal cellular proliferation.
Patients may present with leukocoria, decreased vision, strabismus, or may be asymptomatic with incidental findings on examination. Associated systemic features are common, particularly in congenital infections and genetic syndromes. Diagnosis relies on a thorough ophthalmic examination supported by imaging such as ocular ultrasound (especially useful for detecting calcification in retinoblastoma), MRI or CT for intracranial or orbital involvement, and laboratory testing including TORCH screening and genetic analysis when indicated. Electroretinography can help diagnose retinal dystrophies.
Management depends entirely on the underlying cause. Retinoblastoma requires urgent oncologic management, including chemotherapy and sometimes enucleation. Infectious lesions may require antimicrobial therapy if active, while many congenital scars are inactive and require observation. Developmental anomalies like coloboma are monitored for complications such as retinal detachment, and patients with retinal dystrophies benefit from supportive care and low vision rehabilitation.
Prognosis varies widely. Some lesions, such as inactive scars, may have minimal visual impact, while others like retinoblastoma or Leber congenital amaurosis can lead to severe visual loss or even be life-threatening. Important complications include retinal detachment in coloboma, reactivation in toxoplasmosis, and systemic spread or secondary malignancies in retinoblastoma.
Congenital hypopigmented retinal lesions are a diverse group of conditions characterized by reduced or absent pigmentation of the retinal pigment epithelium (RPE) or choroid present at birth. These lesions are not a single disease entity but rather include a wide spectrum of pathologies such as tumors, congenital infections, retinal dystrophies, and developmental abnormalities. Clinically, they may appear as white or pale areas in the fundus and can vary in size, location, and associated findings.
A critical point in evaluation is that any white retinal lesion in infancy must prompt urgent consideration of Retinoblastoma, a life-threatening malignancy. Other important causes include infectious etiologies such as Toxoplasmosis, Cytomegalovirus infection, and Varicella, which typically produce chorioretinal scars. Developmental anomalies like Coloboma and inherited retinal dystrophies such as Leber congenital amaurosis are also included in the differential diagnosis.
The underlying pathophysiology depends on the cause. In some cases, there is a primary defect in melanin production within the RPE, while in others, such as infections, there is destruction of the RPE. Developmental conditions like coloboma result from failure of closure of the embryonic fissure, leading to absence of normal retinal and choroidal structures. Neoplastic processes, such as retinoblastoma or astrocytic hamartoma, involve abnormal cellular proliferation.
Patients may present with leukocoria, decreased vision, strabismus, or may be asymptomatic with incidental findings on examination. Associated systemic features are common, particularly in congenital infections and genetic syndromes. Diagnosis relies on a thorough ophthalmic examination supported by imaging such as ocular ultrasound (especially useful for detecting calcification in retinoblastoma), MRI or CT for intracranial or orbital involvement, and laboratory testing including TORCH screening and genetic analysis when indicated. Electroretinography can help diagnose retinal dystrophies.
Management depends entirely on the underlying cause. Retinoblastoma requires urgent oncologic management, including chemotherapy and sometimes enucleation. Infectious lesions may require antimicrobial therapy if active, while many congenital scars are inactive and require observation. Developmental anomalies like coloboma are monitored for complications such as retinal detachment, and patients with retinal dystrophies benefit from supportive care and low vision rehabilitation.
Prognosis varies widely. Some lesions, such as inactive scars, may have minimal visual impact, while others like retinoblastoma or Leber congenital amaurosis can lead to severe visual loss or even be life-threatening. Important complications include retinal detachment in coloboma, reactivation in toxoplasmosis, and systemic spread or secondary malignancies in retinoblastoma.
- Published on
Ophthalmology – Conjunctival Primary Acquired Melanosis (PAM)
Conjunctival primary acquired melanosis (PAM) is an acquired, flat pigmentation of the conjunctiva that typically develops in middle-aged or older adults, most often in individuals with lighter skin. It is usually unilateral, nonhereditary, and slowly progressive, and can involve multiple regions of the conjunctiva including the limbus, bulbar surface, fornix, caruncle, and even the tarsal conjunctiva. Unlike conjunctival melanoma, PAM generally lacks prominent vascularity and appears as a patchy, brown discoloration of the ocular surface.
The clinical importance of PAM lies in its potential to act as a precursor to conjunctival melanoma, particularly when atypia is present. Patients often report a gradually enlarging pigmented area on the eye, although many remain asymptomatic. The condition is more common in Caucasians and has been associated with sunlight exposure, though no single definitive risk factor has been identified.
Pathophysiologically, PAM begins as melanocytic proliferation in the basal layer of the conjunctival epithelium. In cases with atypia, these abnormal melanocytes can extend upward through the epithelial layers and eventually penetrate the basement membrane, transforming into invasive melanoma. Histologically, PAM is classified into two main types: without atypia (benign) and with atypia (premalignant). The risk of progression to melanoma is negligible in PAM without atypia but increases significantly with atypia—especially severe atypia, where transformation risk can be very high.
Diagnosis is primarily clinical, supported by careful slit-lamp examination and documentation of lesion extent (often measured in clock hours). Imaging such as anterior segment OCT may help confirm that the lesion is superficial without deeper invasion. In selected cases, biopsy or cytologic evaluation may be performed to assess for atypia, although some clinicians prefer to proceed directly to treatment without prior manipulation.
Management depends on the extent and histologic features of the lesion. Small areas may be observed, especially if atypia is not suspected. More extensive or suspicious lesions are typically treated with surgical excision combined with cryotherapy to surrounding tissue. For diffuse or recurrent disease, topical chemotherapy agents such as mitomycin C may be used, and in extensive cases, even radiotherapy can be considered. The goal is to eliminate abnormal pigmentation and reduce the risk of malignant transformation.
Lifelong follow-up is essential. Patients are usually monitored every 3–4 months initially, then every 6 months once stability is established. Regular examinations focus on detecting growth, recurrence, or transformation into melanoma.
The prognosis is excellent if PAM remains non-atypical. However, once transformation to melanoma occurs, the prognosis becomes more guarded due to the risk of metastasis. Complications from treatment may include ocular surface issues such as dry eye, scarring, symblepharon, and, rarely, vision loss, particularly in advanced or extensively treated cases.
Conjunctival primary acquired melanosis (PAM) is an acquired, flat pigmentation of the conjunctiva that typically develops in middle-aged or older adults, most often in individuals with lighter skin. It is usually unilateral, nonhereditary, and slowly progressive, and can involve multiple regions of the conjunctiva including the limbus, bulbar surface, fornix, caruncle, and even the tarsal conjunctiva. Unlike conjunctival melanoma, PAM generally lacks prominent vascularity and appears as a patchy, brown discoloration of the ocular surface.
The clinical importance of PAM lies in its potential to act as a precursor to conjunctival melanoma, particularly when atypia is present. Patients often report a gradually enlarging pigmented area on the eye, although many remain asymptomatic. The condition is more common in Caucasians and has been associated with sunlight exposure, though no single definitive risk factor has been identified.
Pathophysiologically, PAM begins as melanocytic proliferation in the basal layer of the conjunctival epithelium. In cases with atypia, these abnormal melanocytes can extend upward through the epithelial layers and eventually penetrate the basement membrane, transforming into invasive melanoma. Histologically, PAM is classified into two main types: without atypia (benign) and with atypia (premalignant). The risk of progression to melanoma is negligible in PAM without atypia but increases significantly with atypia—especially severe atypia, where transformation risk can be very high.
Diagnosis is primarily clinical, supported by careful slit-lamp examination and documentation of lesion extent (often measured in clock hours). Imaging such as anterior segment OCT may help confirm that the lesion is superficial without deeper invasion. In selected cases, biopsy or cytologic evaluation may be performed to assess for atypia, although some clinicians prefer to proceed directly to treatment without prior manipulation.
Management depends on the extent and histologic features of the lesion. Small areas may be observed, especially if atypia is not suspected. More extensive or suspicious lesions are typically treated with surgical excision combined with cryotherapy to surrounding tissue. For diffuse or recurrent disease, topical chemotherapy agents such as mitomycin C may be used, and in extensive cases, even radiotherapy can be considered. The goal is to eliminate abnormal pigmentation and reduce the risk of malignant transformation.
Lifelong follow-up is essential. Patients are usually monitored every 3–4 months initially, then every 6 months once stability is established. Regular examinations focus on detecting growth, recurrence, or transformation into melanoma.
The prognosis is excellent if PAM remains non-atypical. However, once transformation to melanoma occurs, the prognosis becomes more guarded due to the risk of metastasis. Complications from treatment may include ocular surface issues such as dry eye, scarring, symblepharon, and, rarely, vision loss, particularly in advanced or extensively treated cases.
- Published on
Ophthalmology – Conjunctival and Corneal Lacerations
Conjunctival and corneal lacerations are tears or cuts of the ocular surface caused by blunt or penetrating trauma. These injuries range from superficial partial-thickness defects to full-thickness open globe injuries, which are vision-threatening emergencies. They are more common in young males and are frequently associated with occupational or recreational activities where protective eyewear is not used.
Patients typically present with pain, redness, tearing, photophobia, and foreign body sensation. A careful history is critical, especially regarding the mechanism of injury, as high-velocity trauma (e.g., metal-on-metal or BB gun injuries) raises strong concern for intraocular foreign body (IOFB) or globe rupture. Determining the timing of last oral intake is also important if urgent surgery is required.
On examination, minimal manipulation of the eye is essential to avoid worsening a possible open globe injury. Visual acuity should always be checked, but intraocular pressure must not be measured if a full-thickness laceration is suspected. Slit-lamp examination helps assess the size, depth, and location of the wound. Fluorescein staining can highlight epithelial defects, and a positive Seidel test confirms aqueous leakage, indicating a full-thickness laceration. Additional concerning signs include irregular pupil, shallow or deep anterior chamber, hyphema, hypotony, or vitreous hemorrhage. Both eyes must be examined carefully, and eyelid eversion should be performed when safe.
If an intraocular foreign body is suspected, orbital CT scan (thin cuts) is the imaging modality of choice, while MRI should be avoided if metallic material is possible. Even with normal imaging, persistent suspicion of globe injury may require surgical exploration.
Management depends on the severity of the injury. Small conjunctival lacerations without scleral involvement often heal with topical antibiotic ointment alone, while larger ones may require suturing. Partial-thickness corneal lacerations are treated with topical antibiotics and close observation, though some may need suturing if wound edges gape. In contrast, full-thickness corneal lacerations are ophthalmic emergencies requiring urgent surgical repair in the operating room. Patients should be protected with a rigid eye shield, kept NPO, and given systemic antibiotics to reduce infection risk. Antiemetics and pain control are important to prevent increases in intraocular pressure.
Surgical repair focuses on restoring globe integrity, carefully repositioning tissues, removing vitreous traction if present, and achieving watertight closure using fine sutures. Associated injuries such as traumatic cataract or iris damage are usually addressed later. Patients must be counseled about the rare but serious risk of sympathetic ophthalmia, which can affect the uninjured eye.
Close follow-up is required to monitor for complications such as infection, retinal detachment, or wound leakage. Children are at particular risk of amblyopia, requiring prompt visual rehabilitation. Prognosis varies widely depending on the severity of injury, timing of treatment, and presence of complications, with worse outcomes associated with delayed care or severe trauma.
Conjunctival and corneal lacerations are tears or cuts of the ocular surface caused by blunt or penetrating trauma. These injuries range from superficial partial-thickness defects to full-thickness open globe injuries, which are vision-threatening emergencies. They are more common in young males and are frequently associated with occupational or recreational activities where protective eyewear is not used.
Patients typically present with pain, redness, tearing, photophobia, and foreign body sensation. A careful history is critical, especially regarding the mechanism of injury, as high-velocity trauma (e.g., metal-on-metal or BB gun injuries) raises strong concern for intraocular foreign body (IOFB) or globe rupture. Determining the timing of last oral intake is also important if urgent surgery is required.
On examination, minimal manipulation of the eye is essential to avoid worsening a possible open globe injury. Visual acuity should always be checked, but intraocular pressure must not be measured if a full-thickness laceration is suspected. Slit-lamp examination helps assess the size, depth, and location of the wound. Fluorescein staining can highlight epithelial defects, and a positive Seidel test confirms aqueous leakage, indicating a full-thickness laceration. Additional concerning signs include irregular pupil, shallow or deep anterior chamber, hyphema, hypotony, or vitreous hemorrhage. Both eyes must be examined carefully, and eyelid eversion should be performed when safe.
If an intraocular foreign body is suspected, orbital CT scan (thin cuts) is the imaging modality of choice, while MRI should be avoided if metallic material is possible. Even with normal imaging, persistent suspicion of globe injury may require surgical exploration.
Management depends on the severity of the injury. Small conjunctival lacerations without scleral involvement often heal with topical antibiotic ointment alone, while larger ones may require suturing. Partial-thickness corneal lacerations are treated with topical antibiotics and close observation, though some may need suturing if wound edges gape. In contrast, full-thickness corneal lacerations are ophthalmic emergencies requiring urgent surgical repair in the operating room. Patients should be protected with a rigid eye shield, kept NPO, and given systemic antibiotics to reduce infection risk. Antiemetics and pain control are important to prevent increases in intraocular pressure.
Surgical repair focuses on restoring globe integrity, carefully repositioning tissues, removing vitreous traction if present, and achieving watertight closure using fine sutures. Associated injuries such as traumatic cataract or iris damage are usually addressed later. Patients must be counseled about the rare but serious risk of sympathetic ophthalmia, which can affect the uninjured eye.
Close follow-up is required to monitor for complications such as infection, retinal detachment, or wound leakage. Children are at particular risk of amblyopia, requiring prompt visual rehabilitation. Prognosis varies widely depending on the severity of injury, timing of treatment, and presence of complications, with worse outcomes associated with delayed care or severe trauma.
- Published on
Ophthalmology – Contact Lens Complications
Contact lens complications can occur in any wearer and range from mild irritation to severe, vision-threatening infections. These complications are broadly categorized into infectious (bacterial, fungal, Acanthamoeba), allergic (giant papillary conjunctivitis), hypoxic (overwear-related), toxic (solution-related), and structural changes such as corneal warpage. Although most issues are preventable, improper lens hygiene and overwear remain major contributors.
The most serious complication is infectious keratitis, particularly bacterial keratitis, which presents with pain, redness, photophobia, and decreased vision. On examination, there is typically a dense corneal infiltrate with an epithelial defect, surrounding edema, and sometimes hypopyon. Fungal keratitis appears more fluffy with satellite lesions, while Acanthamoeba keratitis—often linked to exposure to contaminated water (e.g., lakes, tap water)—causes severe pain out of proportion to findings and may show radial keratoneuritis or a ring infiltrate (late sign).
Noninfectious complications are also common. Contact lens overwear leads to corneal hypoxia, resulting in punctate keratitis, subepithelial infiltrates, and corneal neovascularization. Toxic keratitis can occur from improper use of multipurpose solutions or unneutralized hydrogen peroxide, presenting as diffuse epithelial damage. Giant papillary conjunctivitis (GPC) is an immune-mediated reaction characterized by large papillae on the upper tarsal conjunctiva, itching, and mucus discharge, often related to lens deposits or material.
Diagnosis relies on a careful history of contact lens use, hygiene practices, and symptom onset, along with slit-lamp examination. In suspected infections, corneal scrapings for culture and staining are essential to identify the causative organism and guide therapy.
Management depends on the underlying cause. Bacterial keratitis is treated urgently with frequent topical antibiotics (e.g., fluoroquinolones or fortified antibiotics). Fungal infections require antifungals such as natamycin, while Acanthamoeba keratitis is treated with agents like PHMB and propamidine. Noninfectious conditions improve with cessation of lens use, lubrication, and sometimes topical steroids or antihistamines (for GPC). Severe or nonresponsive infections may require corneal transplantation.
Prevention is critical and includes avoiding overnight wear, proper cleaning and storage, regular replacement of lenses and cases, and avoiding water exposure while wearing lenses. Daily disposable lenses significantly reduce risk.
The prognosis is generally good for mild complications, but central or severe infections can lead to permanent vision loss, especially if treatment is delayed or inappropriate (e.g., steroid use in active infection).
Contact lens complications can occur in any wearer and range from mild irritation to severe, vision-threatening infections. These complications are broadly categorized into infectious (bacterial, fungal, Acanthamoeba), allergic (giant papillary conjunctivitis), hypoxic (overwear-related), toxic (solution-related), and structural changes such as corneal warpage. Although most issues are preventable, improper lens hygiene and overwear remain major contributors.
The most serious complication is infectious keratitis, particularly bacterial keratitis, which presents with pain, redness, photophobia, and decreased vision. On examination, there is typically a dense corneal infiltrate with an epithelial defect, surrounding edema, and sometimes hypopyon. Fungal keratitis appears more fluffy with satellite lesions, while Acanthamoeba keratitis—often linked to exposure to contaminated water (e.g., lakes, tap water)—causes severe pain out of proportion to findings and may show radial keratoneuritis or a ring infiltrate (late sign).
Noninfectious complications are also common. Contact lens overwear leads to corneal hypoxia, resulting in punctate keratitis, subepithelial infiltrates, and corneal neovascularization. Toxic keratitis can occur from improper use of multipurpose solutions or unneutralized hydrogen peroxide, presenting as diffuse epithelial damage. Giant papillary conjunctivitis (GPC) is an immune-mediated reaction characterized by large papillae on the upper tarsal conjunctiva, itching, and mucus discharge, often related to lens deposits or material.
Diagnosis relies on a careful history of contact lens use, hygiene practices, and symptom onset, along with slit-lamp examination. In suspected infections, corneal scrapings for culture and staining are essential to identify the causative organism and guide therapy.
Management depends on the underlying cause. Bacterial keratitis is treated urgently with frequent topical antibiotics (e.g., fluoroquinolones or fortified antibiotics). Fungal infections require antifungals such as natamycin, while Acanthamoeba keratitis is treated with agents like PHMB and propamidine. Noninfectious conditions improve with cessation of lens use, lubrication, and sometimes topical steroids or antihistamines (for GPC). Severe or nonresponsive infections may require corneal transplantation.
Prevention is critical and includes avoiding overnight wear, proper cleaning and storage, regular replacement of lenses and cases, and avoiding water exposure while wearing lenses. Daily disposable lenses significantly reduce risk.
The prognosis is generally good for mild complications, but central or severe infections can lead to permanent vision loss, especially if treatment is delayed or inappropriate (e.g., steroid use in active infection).
- Published on
Ophthalmology – Contact Lens Complications
Contact lens complications can occur in any wearer and range from mild irritation to severe, vision-threatening infections. These complications are broadly categorized into infectious (bacterial, fungal, Acanthamoeba), allergic (giant papillary conjunctivitis), hypoxic (overwear-related), toxic (solution-related), and structural changes such as corneal warpage. Although most issues are preventable, improper lens hygiene and overwear remain major contributors.
The most serious complication is infectious keratitis, particularly bacterial keratitis, which presents with pain, redness, photophobia, and decreased vision. On examination, there is typically a dense corneal infiltrate with an epithelial defect, surrounding edema, and sometimes hypopyon. Fungal keratitis appears more fluffy with satellite lesions, while Acanthamoeba keratitis—often linked to exposure to contaminated water (e.g., lakes, tap water)—causes severe pain out of proportion to findings and may show radial keratoneuritis or a ring infiltrate (late sign).
Noninfectious complications are also common. Contact lens overwear leads to corneal hypoxia, resulting in punctate keratitis, subepithelial infiltrates, and corneal neovascularization. Toxic keratitis can occur from improper use of multipurpose solutions or unneutralized hydrogen peroxide, presenting as diffuse epithelial damage. Giant papillary conjunctivitis (GPC) is an immune-mediated reaction characterized by large papillae on the upper tarsal conjunctiva, itching, and mucus discharge, often related to lens deposits or material.
Diagnosis relies on a careful history of contact lens use, hygiene practices, and symptom onset, along with slit-lamp examination. In suspected infections, corneal scrapings for culture and staining are essential to identify the causative organism and guide therapy.
Management depends on the underlying cause. Bacterial keratitis is treated urgently with frequent topical antibiotics (e.g., fluoroquinolones or fortified antibiotics). Fungal infections require antifungals such as natamycin, while Acanthamoeba keratitis is treated with agents like PHMB and propamidine. Noninfectious conditions improve with cessation of lens use, lubrication, and sometimes topical steroids or antihistamines (for GPC). Severe or nonresponsive infections may require corneal transplantation.
Prevention is critical and includes avoiding overnight wear, proper cleaning and storage, regular replacement of lenses and cases, and avoiding water exposure while wearing lenses. Daily disposable lenses significantly reduce risk.
The prognosis is generally good for mild complications, but central or severe infections can lead to permanent vision loss, especially if treatment is delayed or inappropriate (e.g., steroid use in active infection).
Contact lens complications can occur in any wearer and range from mild irritation to severe, vision-threatening infections. These complications are broadly categorized into infectious (bacterial, fungal, Acanthamoeba), allergic (giant papillary conjunctivitis), hypoxic (overwear-related), toxic (solution-related), and structural changes such as corneal warpage. Although most issues are preventable, improper lens hygiene and overwear remain major contributors.
The most serious complication is infectious keratitis, particularly bacterial keratitis, which presents with pain, redness, photophobia, and decreased vision. On examination, there is typically a dense corneal infiltrate with an epithelial defect, surrounding edema, and sometimes hypopyon. Fungal keratitis appears more fluffy with satellite lesions, while Acanthamoeba keratitis—often linked to exposure to contaminated water (e.g., lakes, tap water)—causes severe pain out of proportion to findings and may show radial keratoneuritis or a ring infiltrate (late sign).
Noninfectious complications are also common. Contact lens overwear leads to corneal hypoxia, resulting in punctate keratitis, subepithelial infiltrates, and corneal neovascularization. Toxic keratitis can occur from improper use of multipurpose solutions or unneutralized hydrogen peroxide, presenting as diffuse epithelial damage. Giant papillary conjunctivitis (GPC) is an immune-mediated reaction characterized by large papillae on the upper tarsal conjunctiva, itching, and mucus discharge, often related to lens deposits or material.
Diagnosis relies on a careful history of contact lens use, hygiene practices, and symptom onset, along with slit-lamp examination. In suspected infections, corneal scrapings for culture and staining are essential to identify the causative organism and guide therapy.
Management depends on the underlying cause. Bacterial keratitis is treated urgently with frequent topical antibiotics (e.g., fluoroquinolones or fortified antibiotics). Fungal infections require antifungals such as natamycin, while Acanthamoeba keratitis is treated with agents like PHMB and propamidine. Noninfectious conditions improve with cessation of lens use, lubrication, and sometimes topical steroids or antihistamines (for GPC). Severe or nonresponsive infections may require corneal transplantation.
Prevention is critical and includes avoiding overnight wear, proper cleaning and storage, regular replacement of lenses and cases, and avoiding water exposure while wearing lenses. Daily disposable lenses significantly reduce risk.
The prognosis is generally good for mild complications, but central or severe infections can lead to permanent vision loss, especially if treatment is delayed or inappropriate (e.g., steroid use in active infection).
- Published on
Ophthalmology – Acute Bacterial Conjunctivitis
Acute bacterial conjunctivitis is a common inflammation of the conjunctiva, the mucous membrane lining the inner eyelids and covering the sclera. It affects individuals of all ages and is particularly frequent in children, where bacteria account for the majority of infectious conjunctivitis cases. The condition is highly contagious and represents a significant portion of primary care and ophthalmology visits.
Patients typically present with a red eye accompanied by purulent (yellow-green) discharge, which often leads to eyelid crusting or “glued eyes” upon waking. Symptoms frequently involve both eyes, though one eye may be affected first. Other features include irritation, tearing, and mild discomfort. Unlike viral conjunctivitis, watery discharge is less prominent, and severe pain or vision loss should prompt evaluation for alternative diagnoses. In hyperacute cases—most notably caused by Neisseria gonorrhoeae—patients may develop copious discharge and rapid progression, posing a risk for corneal damage.
The most common causative organisms include Staphylococcus aureus (more common in adults), Haemophilus influenzae and Streptococcus pneumoniae (common in children), and Moraxella catarrhalis. Chronic cases may be caused by Chlamydia, while hyperacute cases are associated with gonococcal infection. Risk factors include close contact with infected individuals, sinusitis, and immunocompromised states.
Diagnosis is usually clinical, though it can be challenging to distinguish from viral conjunctivitis based on symptoms alone. On examination, findings may include conjunctival injection, papillary reaction, and purulent discharge. Preauricular lymphadenopathy is uncommon in bacterial cases. Laboratory testing (culture or Gram stain) is reserved for severe, recurrent, or nonresponsive cases, or when gonococcal or chlamydial infection is suspected.
Treatment typically involves topical antibiotics, which shorten the duration of symptoms and reduce transmission. First-line options include trimethoprim-polymyxin B or fluoroquinolone eye drops for about 7 days. Hyperacute gonococcal conjunctivitis requires systemic antibiotics such as intramuscular ceftriaxone, often combined with topical therapy and close follow-up due to the risk of corneal ulceration and perforation. Supportive care includes artificial tears, good hygiene, and avoidance of sharing personal items.
The prognosis is excellent, as most cases are self-limiting, even without treatment. However, antibiotics speed recovery and reduce spread. Patients should be advised that they remain contagious for 24–48 hours after starting antibiotics. Follow-up is recommended if symptoms worsen, vision decreases, or there is no improvement within a week. Complications are rare but may include keratitis in severe or untreated cases.
Acute bacterial conjunctivitis is a common inflammation of the conjunctiva, the mucous membrane lining the inner eyelids and covering the sclera. It affects individuals of all ages and is particularly frequent in children, where bacteria account for the majority of infectious conjunctivitis cases. The condition is highly contagious and represents a significant portion of primary care and ophthalmology visits.
Patients typically present with a red eye accompanied by purulent (yellow-green) discharge, which often leads to eyelid crusting or “glued eyes” upon waking. Symptoms frequently involve both eyes, though one eye may be affected first. Other features include irritation, tearing, and mild discomfort. Unlike viral conjunctivitis, watery discharge is less prominent, and severe pain or vision loss should prompt evaluation for alternative diagnoses. In hyperacute cases—most notably caused by Neisseria gonorrhoeae—patients may develop copious discharge and rapid progression, posing a risk for corneal damage.
The most common causative organisms include Staphylococcus aureus (more common in adults), Haemophilus influenzae and Streptococcus pneumoniae (common in children), and Moraxella catarrhalis. Chronic cases may be caused by Chlamydia, while hyperacute cases are associated with gonococcal infection. Risk factors include close contact with infected individuals, sinusitis, and immunocompromised states.
Diagnosis is usually clinical, though it can be challenging to distinguish from viral conjunctivitis based on symptoms alone. On examination, findings may include conjunctival injection, papillary reaction, and purulent discharge. Preauricular lymphadenopathy is uncommon in bacterial cases. Laboratory testing (culture or Gram stain) is reserved for severe, recurrent, or nonresponsive cases, or when gonococcal or chlamydial infection is suspected.
Treatment typically involves topical antibiotics, which shorten the duration of symptoms and reduce transmission. First-line options include trimethoprim-polymyxin B or fluoroquinolone eye drops for about 7 days. Hyperacute gonococcal conjunctivitis requires systemic antibiotics such as intramuscular ceftriaxone, often combined with topical therapy and close follow-up due to the risk of corneal ulceration and perforation. Supportive care includes artificial tears, good hygiene, and avoidance of sharing personal items.
The prognosis is excellent, as most cases are self-limiting, even without treatment. However, antibiotics speed recovery and reduce spread. Patients should be advised that they remain contagious for 24–48 hours after starting antibiotics. Follow-up is recommended if symptoms worsen, vision decreases, or there is no improvement within a week. Complications are rare but may include keratitis in severe or untreated cases.
